| G(M2)-GANGLIOSIDOSIS: GM2 ACTIVATOR DEFICIENCY | |
| TAY-SACHS DISEASE, AB VARIANT; G(M2)-GANGLIOSIDOSIS WITH HEXOAMINIDASE A DEFICIENCY | |
|
272750
OMIM = Online Mendelian Inheritance of Men | |
|
309246 | |
| Ganglioside GM2 activator | |
| 5q33.1 Detail information to gene locus by the National Center for Biotechnology Information NCBI: |
|
| E75.0 | |
| very rare autosomal recessive mutation in the GM2A gene infantile acute form, indistinguishable from infantile Tay-Sachs or Sandhoff disease | |
| Laboratory findings | Oligosaccharides inc (urine) GM2 activator protein dec (fibroblasts) L-Pyroglutamic acid (5-Oxoproline) inc (urine) |
| Symptoms | blindness, visual loss, visual impairment cherry-red spot on retinal macula early death EEG abnormalities [-] hypertonia, spasticity hypotonia lethargy, drowsiness, apathy macrocephaly (large calvaria, >2 SD for age) mental retardation onset, infancy progressive neurologic defect seizures speech difficulties |